Intestinal trefoil factor (TFF 3) and pS2 (TFF 1), but not spasmolytic polypeptide (TFF 2) mRNAs are co-expressed in normal, hyperplastic, and neoplastic human breast epithelium

Journal of Pathology

Volumn 183, Issue 1, 1997, Pages 30-38

  Poulsom, Richard ^a   Hanby, Andrew M ^a   Lalani, El Nasir ^a,b   Hauser, Frank ^c   Hoffmann, Werner ^c,d   Stamp, Gordon W H ^a,b  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^d OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

BCEI; Breast cancer; hITF hPI.B TFF 3; Human spasmolytic polypeptide; in situ hybridization; P domain; pS2 TFF 1; TFF 2; Trefoil factor

Indexed keywords

ESTROGEN; INTESTINAL TREFOIL FACTOR;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CELL MOTILITY; CELL SPREADING; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RECEPTOR BINDING;

BLOTTING, NORTHERN; BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; GROWTH SUBSTANCES; HUMANS; HYPERPLASIA; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; MUCINS; MUSCLE PROTEINS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEUROPEPTIDES; PEPTIDES; PRECANCEROUS CONDITIONS; PROTEINS; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEINS;

EID: 0030864842     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199709)183:1<30::AID-PATH1085>3.0.CO;2-K     Document Type: Article

References (35)

1. Lefebvre O, Chenard M-P, Masson R, et al. Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science 1996; 274: 259-262.
2. Thim L. Trefoil peptides: a new family of gastrointestinal molecules. Digestion 1994; 55: 353-360.
3. Poulsom R, Wright NA. Trefoil peptides: a newly recognized family of epithelial mucin-associated molecules. Am J Physiol 1993; 265: 9205-9213.
4. Williams R, Lalani EN, Stamp GW. Natural gastrointestinal ulcer healing mechanism? (Editorial). J R Soc Med 1994; 87: 649-651.
5. Hauser F, Hoffmann W. xP1 and xP4. P-domain peptides expressed in Xenopus laevis stomach mucosa. J Biol Chem 1991; 266: 21306-21309.
6. Wright NA, Poulsom R, Stamp GW, et al. Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues. J Pathol 1990; 162: 279-284.
7. Wright NA, Poulsom R, Stamp G, et al. Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease. Gastroenterology 1993; 104: 12-20.
8. Hanby AM, Wright NA. The ulcer-associated cell lineage, the gastrointestinal repair kit? (Editorial). J Pathol 1993; 171: 3-4.
9. Alison MR, Chinery R, Poulsom R, Ashwood P, Longcroft JM, Wright NA. Experimental ulceration leads to sequential expression of spasmolytic polypeptide, intestinal trefoil factor, epidermal growth factor and transforming growth factor alpha mRNAs in rat stomach. J Pathol 1995; 175: 405-414.
10. Williams R, Lalani E-N, Elia G, Stamp GWH. Non-precursor and precursor lesions of pancreatic cancer. In: Neoptolemos JP, Lemoine NR, eds. Pancreatic Cancer: Molecular and Clinical Advances. Oxford: Blackwell Science, 1996; 92-104.
11. Dignass A, Lynch DK, Kindon H, Thim L, Podolsky DK. Trefoil peptides promote epithelial migration through a transforming growth factor beta-independent pathway. J Clin Invest 1994; 94: 376-383.
12. Playford RJ, Marchbank T, Chinery R, et al. Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration. Gastroenterology 1995; 108: 108-116.
13. Williams R, Stamp GWH, Gilbert C, Pignatelli M, Lalani E-N. pS2 transfection of murine adenocarcinoma cell line (410.4) enhances dispersed growth pattern in 3-D collagen gel. J Cell Sci 1996; 109: 63-71.
14. Masiakowski P, Breathnach R, Bloch J, Gannon F, Krust A, Chambon P. Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. Nucleic Acids Res 1982; 10: 7895-7903.
15. Tomasetto C, Rockel N, Mattei MG, Fujita R, Rio MC. The gene encoding the human spasmolytic protein (SML1/hSP) is in 21q22.3, physically linked to the homologous breast cancer marker gene BCEI/pS2. Genomics 1992; 13: 1328-1330.
16. Berry M, Nunez AM, Chambon P. Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence. Proc Natl Acad Sci USA 1989; 86: 1218-1222.
17. Henry JA, Bennett MK, Piggott NH, Levett DL, May FE, Westley BR. Expression of the pNR-2/pS2 protein in diverse human epithelial tumours. Br J Cancer 1991; 64: 677-682.
18. Soubeyran I, Wafflart J, Bonichon F, et al. Immunohistochemical determination of pS2 in invasive breast carcinomas: a study on 942 cases. Breast Cancer Res Treat 1995; 34: 119-128.
19. Theisinger B, Seitz G, Dooley S, Cornelius W. A second trefoil protein, ITF/HP1.B, is transcribed in human breast cancer. Breast Cancer Res Treat 1996; 38: 145-151.
20. Hauser F, Poulsom R, Chinery R, et al. hP1.B, a human P-domain peptide homologous with rat intestinal trefoil factor, is expressed also in the ulcer-associated cell lineage and the uterus. Proc Natl Acad Sci USA 1993; 90: 6961-6965.
21. Probst JC, Skutella T, Muller-Schmid A, Jirikowski GF, Hoffman W. Molecular and cellular analysis of rP1.B in the rat hypothalamus: in situ hybridization and immunohistochemistry of a new P-domain neuropeptide. Mol Brain Res. 1995; 33: 269-276.
22. Rio MC, Bellocq JP, Daniel JY, et al. Breast cancer-associated pS2 protein: synthesis and secretion by normal stomach mucosa. Science 1988; 241: 705-708.
23. Senior PV, Critchley DR, Beck F, Walker RA, Varley JM. The localization of laminin mRNA and protein in the postimplantation embryo and placenta of the mouse: an in situ hybridization and immunocytochemical study. Development 1988; 104: 431-446.
24. Jakowlew SB, Breathnach R, Jeltsch JM, Masiakowski P, Chambon P. Sequence of the pS2 mRNA induced by estrogen in the human breast cancer cell line MCF-7. Nucleic Acids Res 1984; 12: 2861-2878.
25. Tomasetto C, Rio MC, Gautier C, et al. hSP, the domain-duplicated homolog of pS2 protein, is co-expressed with pS2 in stomach but not in breast carcinoma. EMBO J 1990; 9: 407-414.
26. Zandvliet DWJ, Hanby AM, Austin CA, et al. Analysis of foetal expression sites of human type II DNA topoisomerase α and β mRNAs by in situ hybridisation. Biochim Biophys Acta 1996; 1307: 239-247.
27. Williams R, Elia G, Stamp GWH, et al. Characterisation of monoclonal antibodies raised to C-terminal peptides of pS2. Hum Pathol 1996;
28. Elia G, Chinery R, Hanby AM, Poulsom R, Wright NA. The production and characterization of a new monoclonal antibody to the trefoil peptide human spasmolytic polypeptide. Histochem J 1994; 26: 644-647.
29. Theisinger B, Seitz G, Dooley S, Cornelius W. A second trefoil protein. ITF/HP1.B, is transcribed in human breast cancer. Breast Cancer Res Treat 1996; 38: 145-151.
30. Foekens JA, Rio M-C, Seguin P, et al. Prediction of relapse and survival in breast cancer patients by protein status. Cancer Res 1990; 50: 3832-3837.
31. Foekens JA, PW van H, Portengen KH de, Thirion B, Alexieva FJ, Klijn JG. Prognostic value of PS2 and cathepsin D in 710 human primary breast tumors: multivariate analysis. J Clin Oncol 1993; 11: 899-908.
32. Seib T, Dooley S, Welter C. Characterisation of the genomic structure and the promoter region of the human intestinal trefoil factor. Biochem Biophys Res Commun 1995; 214: 195-199.
33. Chinery R, Bates PA, De A, Freemont PS. Characterisation of the single copy trefoil peptides intestinal trefoil factor and pS2 and their ability to form covalent dimers. FEBS Lett 1995; 357: 50-54.
34. Chinery R, Cox HM. Immunoprecipitation and characterization of a binding protein specific for the peptide intestinal trefoil factor. Peptides 1995; 16: 749-755.
35. Tomasetto C, Wolf C, Rio MC, et al. Breast cancer protein PS2 synthesis in mammary gland of transgenic mice and secretion into milk. Mol Endocrinol 1989; 3: 1579-1584.